The PROSPER trial [1] (multiple letters)

Lancet

Volumn 361, Issue 9355, 2003, Pages 427-428

  Mascitelli, Luca ^a   Pezzetta, Francesca ^b   Srefanec, Tihomir ^c   Goldstein, Mark R ^d   Fiorenza, Anna M ^e   Sommariva, Domenico ^e   Branchi, Adriana ^f   Shepherd, James ^g   Blauw, Gerard J ^g   Murphy, Michael B ^g   Little, Peter J ^h  

^a Casa di Cura Citta di Udine   (Italy)

^b Pronto Soccorso Area d'Emergenza O   (Italy)

^c MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^d DEPARTMENT OF COLORECTAL SURGERY   (United States)

^e RHO HOSPITAL   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g GLASGOW ROYAL INFIRMARY   (United Kingdom)

^h NONE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; HYPOCHOLESTEROLEMIC AGENT; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN A;

AGE; BONE MARROW CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SIZE; CANCER SUSCEPTIBILITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY RISK; DIGESTIVE SYSTEM CANCER; DISEASE MARKER; DRUG EFFECT; DRUG PENETRATION; ENDOTHELIUM CELL; FOLLOW UP; HEART PROTECTION; HUMAN; HYDROPHILICITY; IMMUNE SYSTEM; INFLAMMATION; ISCHEMIC HEART DISEASE; LETTER; LIVER CELL; MALIGNANT TRANSFORMATION; MORTALITY; MYOPATHY; NATURAL KILLER CELL; NEOVASCULARIZATION (PATHOLOGY); PHENOTYPE; PRECANCER; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SIDE EFFECT; SOLID TUMOR; STEM CELL; TRIACYLGLYCEROL BLOOD LEVEL; AGED; AGING; CHEMICALLY INDUCED DISORDER; NEOPLASM; NOTE; PHYSIOLOGY; PREDICTION AND FORECASTING; BLOOD; CARDIOVASCULAR DISEASE; IMMUNOLOGY; METABOLISM; METHODOLOGY; PATIENT SELECTION; CORONARY ARTERY DISEASE; INCIDENCE;

AGE FACTORS; AGED; AGING; ANTICHOLESTEREMIC AGENTS; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PRAVASTATIN; PREDICTIVE VALUE OF TESTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; INFLAMMATION; PATIENT SELECTION; PRIMARY PREVENTION; RISK FACTORS; CORONARY DISEASE; INCIDENCE; KILLER CELLS, NATURAL;

EID: 0037310123     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12397-5     Document Type: Letter

References (0)